Material Agreements

HPS Corporate Lending Fund entered into Commitment Increase Agreement with Truist Bank, U.S. Bank National Association, Sumitomo Mitsui Banking Corporation, Royal Bank of Canada, BNP Paribas valued at Increase of aggregate commitments from $2,250,000,000 to $2,650,000,000 (effective 2026-02-27).

“if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01. Entry into a Material Definitive Agreement On February 27, 2026, HPS Corporate Lending Fund (the “ Fund ”) entered into a Commitment Increase Agreement (the “ Commitment Increase Agreement ”) among the Fund, Truist Bank, as the assuming lender (the “ Assuming Lender ”), and U.S. Bank National Association, Sumitomo Mitsui Banking Corporation, Royal Bank of Canada and BNP Paribas, as the increasing lenders (together, the “ Increasing Lenders ”), JPMorgan Chase Bank, N.A., as administrative agent and as issuing bank, and the issuing banks party thereto, pursuant to the Fund’s Senior Secured Revolving Credit Agreement, dated as of June 23, 2022, among the Fund, as borrower, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as administrative agent and as coll”

Healthcare Triangle, Inc. entered into Placement Agency Agreement with D. Boral Capital LLC (effective 2026-02-26).

“In connection with the Offering, the Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with D. Boral Capital LLC (the “Placement Agent”), pursuant to which the Company paid the Placement Agent (i) a cash fee equal to 7% of the aggregate gross proceeds of the Offering, and (ii) reimbursed the Placement Agent for certain expenses and legal fees.”

Healthcare Triangle, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $3.95 million (effective 2026-02-26).

“On February 26, 2026, Healthcare Triangle, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering (A) an aggregate of 421,553 shares (the “Shares”) of common stock, par value $0.00001 per share (the “Common Stock”), of the Company, at an offering price of $5.81 per share, and (B) 260,000 pre-funded warrants (the “Pre-Funded Warrants”) in lieu of shares of Common Stock, at an offering price of $5.80999 (such registered direct offering, the “Offering”) for aggregate gross proceeds of approximately $3.95 million, before deducting Offering expenses payable by the Company, including the Placement Agent’s commissions and fees.”

Intuitive Machines, Inc. entered into Securities Purchase Agreement with certain institutional investors or their affiliates (collectively, the "Investors") led by global institutional investors valued at $175 million (effective 2026-02-25).

“On February 27, 2026 (the “ Closing Date ”), Intuitive Machines, Inc. (the “ Company ”), a Delaware corporation, completed the previously announced issuance and sale of shares of the Company’s Class A common stock, par value $0.0001 per share (the “ Common Stock ”) at a price of $15.12 per share for an aggregate purchase price of $175 million to certain institutional investors or their affiliates (collectively, the “ Investors ”) led by global institutional investors pursuant to the terms of the Securities Purchase Agreement, dated as of February 25, 2026 (the “ Purchase Agreement ”).”

KORE Group Holdings, Inc. entered into Agreement and Plan of Merger with KONA Parent, L.P. and KONA Merger Sub Co. valued at $9.25 per share in cash (effective 2026-02-26).

“On February 26, 2026, KORE Group Holdings, Inc. (“KORE” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with KONA Parent, L.P., a Delaware limited partnership (“Parent”), and KONA Merger Sub Co., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, subject to the terms and conditions thereof, Merger Sub will merge with and into the Company (the “Merger”) with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent.”

Fold Holdings, Inc. terminated Investor Note with a certain holder named therein valued at approximately $27.5 million in cash ($20 million principal plus $7.5 million multiple) (effective 2026-02-27).

“Subsequent to the closing of the Purchase Agreement, as described above, on February 27, 2026, the Company extinguished the Convertible Note (the "Investor Note") dated December 24, 2024, as amended from time to time, issued by the Company to a certain holder named therein, and terminated the related Securities Purchase Agreement and other transaction documents with the holder pursuant to which such note was purchased.”

Fold Holdings, Inc. terminated March 2025 Note with SATS Credit Fund L.P. valued at approximately $46.3 million face value, convertible into 3.7 million shares at $12.50 per share, col (effective 2026-02-26).

“On February 25, 2026, the Company returned the 500 bitcoin held as collateral pursuant to the March 2025 Note, and on February 26, 2026, upon mutual consent of the parties, the March 2025 Note was extinguished and the related Securities Purchase Agreement was terminated.”

Fold Holdings, Inc. entered into Purchase Agreement with SATS Credit Fund L.P. valued at $13.0 million promissory note and 520,000 shares of Common Stock (effective 2026-02-25).

“Contemporaneously with the termination (as described below) of the March 2025 Note (as defined below), Fold Holdings, Inc. (the "Company") entered into a Purchase Agreement with SATS Credit Fund L.P. ("SATS") dated February 25, 2026 (the "Purchase Agreement"), pursuant to which SATS purchased from the Company a $13.0 million promissory note, repayable in cash (the "New Note") and 520,000 shares of the Company's Common Stock (the "Initial Commitment Shares").”

GE HealthCare Technologies Inc. terminated 2025 364-Day Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

“In connection with the Company’s entry into the New Revolving Credit Agreement, the 2025 364-Day Revolving Credit Agreement, which provided for a $0.5 billion 364-day senior unsecured revolving credit facility, was terminated without penalty on February 26, 2026.”

GE HealthCare Technologies Inc. entered into New Revolving Credit Agreement with JPMorgan Chase Bank, N.A. and the lenders named therein valued at $0.5 billion (effective 2026-02-26).

“On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving credit facility in an aggregate committed amount of $0.5 billion.”

Kinetic Seas Inc. entered into Securities Purchase Agreement with LABRYS FUND II, L.P. valued at $148,500 (effective 2026-02-23).

“On February 23, 2026, Kinetic Seas Incorporated (the “Company”) entered into a Securities Purchase Agreement with LABRYS FUND II, L.P. pursuant to which the Company issued an unsecured promissory note (the “Note”) in the principal amount of $148,500 for gross proceeds of $135,000.”

FrontView REIT, Inc. entered into First Amendment to the Amended and Restated Partnership Agreement of FrontView Operating Partnership LP with FrontView Operating Partnership LP valued at Creation of Series A Convertible Preferred Units with terms substantially similar to Series A Prefer (effective 2026-02-10).

“On February 10, 2026, the Company, as sole general partner of FrontView Operating Partnership LP (the “Operating Partnership”), entered into an amendment (the “OP Amendment”) to the amended and restated partnership agreement of the Operating Partnership (the “Partnership Agreement”).”

FrontView REIT, Inc. entered into Series A Convertible Preferred Stock Purchase with Maewyn FVR II LP, Rebound Investment, LP, Petrus Special Situations Fund, L.P. valued at 250,000 shares of Series A Convertible Preferred Stock at $100.00/share, approximately $25.0 million (effective 2026-02-10).

“On February 10, 2026, the Company, issued an aggregate of 250,000 shares of Series A Convertible Preferred Stock, par value $0.01 per share (the “Series A Preferred Stock”) for $100.00 per share for gross proceeds of approximately $25.0 million to Maewyn FVR II LP (the “Maewyn Purchaser”), Rebound Investment, LP and Petrus Special Situations Fund, L.P. (collectively, the “Purchasers”).”

FrontView REIT, Inc. entered into Distribution Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC (a valued at up to $75,000,000 (effective 2026-02-27).

“On February 27, 2026, FrontView REIT, Inc. (the “ Company ”) and FrontView Operating Partnership, the Company’s operating partnership (the “ OP ”), entered into a distribution agreement (as it may be amended from time to time, the “ Distribution Agreement ”) with each of J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC (and certain of their respective affiliates or agents and other parties named below), acting in their capacity as Agents (as described below), each of J.P. Morgan Securities LLC, BofA Securities, Inc., B. Riley Securities, Inc., Huntington Securities, Inc., Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, Nomura Securities International, Inc. (acting through BTIG, LLC as its agent), RBC Capital Markets, LLC,”

Hashdex Nasdaq CME Crypto Index ETF amended Amendment #1 with Virtu Americas LLC (effective 2026-02-24).

“On February 24, 2026, Hashdex Nasdaq CME Crypto Index ETF (the “Trust”) and Hashdex Asset Management Ltd., as sponsor of the Trust (the “Sponsor”), entered into Amendment #1 (the “Amendment”) to the Authorized Participant Agreement, dated as of January 14, 2025 (the “AP Agreement”), with Virtu Americas LLC (“Virtu”).”

Roman DBDR Acquisition Corp. II entered into Business Combination Agreement with ThomasLloyd Climate Solutions B.V., holders of ThomasLloyd's outstanding ordinary shares, TL Topco PLC, ThomasLloyd Climate Solutions Merger Sub (effective 2026-02-27).

“On February 27, 2026, Roman DBDR Acquisition Corp. II, a Cayman Islands exempted company (“ Roman ”), ThomasLloyd Climate Solutions B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ), with its corporate seat in Amsterdam, the Netherlands (“ ThomasLloyd ”), and each of the holders of ThomasLloyd’s outstanding ordinary shares as named in the Business Combination Agreement (the “ Sellers ”), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement ”).”

VisionWave Holdings, Inc. amended First Amendment with Matania (Mati) Moskovich, C.M. Composite Materials Ltd. (effective 2026-02-26).

“On February 26, 2026, the Company entered into the First Amendment (the “Amendment”) to that certain Investment and Share Purchase Agreement, dated as of February 20, 2026 (the “SPA”), by and among the Company (“Buyer”), Matania (Mati) Moskovich (the “Seller”), and, solely for purposes of acknowledgment and certain covenants therein, C.M. Composite Materials Ltd., an Israeli limited liability company (the “CM Company”).”

VisionWave Holdings, Inc. entered into Letter Agreement with YA II PN, Ltd. valued at $20,000,000 (effective 2026-02-26).

“On February 26, 2026, VisionWave Holdings Inc. (the “Company”) entered into a Letter Agreement (the “Letter Agreement”) with YA II PN, Ltd. (the “Investor”), pursuant to which the Investor agreed to provide the Company with a $20,000,000 senior loan”

CNL Strategic Residential Credit, Inc. amended Amendment No. 1 to the Expense Support and Conditional Reimbursement Agreement with Residential Credit Manager, LLC and Balbec Capital Management, L.P. (effective 2026-01-01).

“On February 27, 2026, the Company entered into Amendment No. 1 to the Expense Support and Conditional Reimbursement Agreement (the “First Amendment”) amending that certain the Expense Support and Conditional Reimbursement Agreement by and among the Company, Residential Credit Manager, LLC and Balbec Capital Management, L.P. dated May 6, 2025 (the “Expense Support Agreement”). The First Amendment extends the period where the Expense Support Amount obligation may be equal to any negative Available Operating Funds (as defined in the Expense Support Agreement) from December 31, 2025 to December 31, 2026. The First Amendment has an effective date of January 1, 2026.”

Atrium Therapeutics, Inc. entered into Transition Services Agreement with Avidity Biosciences, Inc. valued at Company and Avidity entered into a Transition Services Agreement pursuant to which Avidity will prov (effective 2026-02-26).

“☐ Item 1.01 Entry into a Material Definitive Agreement On February 26, 2026, Avidity Biosciences, Inc. (“Avidity”) completed the previously announced separation of all of its assets and liabilities exclusively related to its early stage precision cardiology programs, including ATR 1086 and ATR 1072, and certain collaboration agreements, consisting of those with Bristol-Myers Squibb Company and Eli Lilly and Company, into a separate, independent publicly traded company (the “Separation”), Atrium Therapeutics, Inc.”

Atrium Therapeutics, Inc. entered into Amended and Restated License Agreement with Avidity Biosciences, Inc. valued at Company entered into an Amended and Restated License Agreement with Avidity, amending the original l (effective 2026-02-26).

“On February 26, 2026, the Company entered into an Amended and Restated License Agreement (“Amended and Restated License Agreement”) with Avidity amending the original license agreement between the Company and Avidity, dated October 25, 2025 (the “Original License Agreement”), pursuant to which the Company granted to Avidity certain exclusive and non-exclusive licenses under the Company’s platform technology and other intellectual property, and Avidity granted to the Company certain exclusive and non-exclusive licenses under certain intellectual property owned or controlled by Avidity and its subsidiaries following the Separation, as further described in the section of the Information Statement (the “Information Statement”) entitled “Business—Intellectual Property—RemainCo License Agreement” filed as Exhibit 99.1 to Amendment No. 2 to the Registration Statement on Form 10 (the “Form 10”), filed by the Company with the Securities and Exchange Commission on February 17, 2026.”

Clearthink 1 Acquisition Corp. entered into Administrative Services Agreement with ClearThink 1 Sponsor LLC valued at Agreement for administrative services provided by sponsor to the company. (effective 2026-02-25).

“An Administrative Services Agreement, dated February 25, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Investment Management Trust Agreement with Equiniti Trust Company, LLC valued at Trust agreement for proceeds from IPO held in trust until business combination. (effective 2026-02-25).

“An Investment Management Trust Agreement, dated February 25, 2026, by and between the Company and Equiniti Trust Company, LLC, as trustee, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Registration Rights Agreement with ClearThink 1 Sponsor LLC and certain other security holders valued at Registration rights granted to sponsor and certain security holders. (effective 2026-02-25).

“A Registration Rights Agreement, dated February 25, 2026, by and among the Company, the Sponsor and certain other security holders named therein, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Insider Letter Agreement with ClearThink 1 Sponsor LLC valued at Agreement with sponsor, officers, directors, and underwriter regarding lock-up and other obligations (effective 2026-02-25).

“An Insider Letter Agreement, dated February 25, 2026, by and between the Company and ClearThink 1 Sponsor LLC (the “Sponsor”), each of its officers and directors, and DBC, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference (the “Insider Letter Agreement”);”

Clearthink 1 Acquisition Corp. entered into Rights Agreement with VStock Transfer, LLC valued at Agreement governing rights attached to Units, each right entitling holder to receive one-fifth of an (effective 2026-02-25).

“A Rights Agreement, dated February 25, 2026, by and between the Company and VStock Transfer, LLC, as rights agent, a copy of which includes the form of rights certificate, is attached as Exhibit 4.1 hereto and incorporated herein by reference;”

Clearthink 1 Acquisition Corp. entered into Underwriting Agreement with D. Boral Capital LLC valued at IPO of 12,500,000 units at $10.00 per unit, gross proceeds $125,000,000 (effective 2026-02-23).

“An Underwriting Agreement, dated February 23, 2026, by and between the Company and D. Boral Capital LLC (“DBC”), acting as representative of the underwriters named therein, which contains customary representations and warranties and indemnification of the underwriters by the Company and is attached as Exhibit 1.1 hereto and incorporated herein by reference;”

MOZAYYX Acquisition Corp. entered into Indemnity Agreements with each director and executive officer of the Company valued at Indemnity agreements with directors and officers (effective 2026-02-24).

“Indemnity Agreements, dated February 24, 2026 (each, an “ Indemnity Agreement ”), by and among the Company and each director and executive officer of the Company, a form of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Letter Agreement with MOZAYYX Acquisition Sponsor LLC valued at Letter agreement among Company, officers, directors and sponsor (effective 2026-02-24).

“A Letter Agreement, dated February 24, 2026 (the “ Letter Agreement ”), by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Representative Private Placement Warrants Purchase Agreement with Cantor Fitzgerald & Co. valued at Private placement warrants purchase agreement with representative (effective 2026-02-24).

“A Private Placement Warrants Purchase Agreement, dated February 24, 2026 (the “ Representative Private Placement Warrants Purchase Agreement ”), by and between the Company and the Representative, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Sponsor Private Placement Warrants Purchase Agreement with MOZAYYX Acquisition Sponsor LLC valued at Private placement warrants purchase agreement with sponsor (effective 2026-02-24).

“A Private Placement Warrants Purchase Agreement, dated February 24, 2026 (the “ Sponsor Private Placement Warrants Purchase Agreement ”), by and between the Company and MOZAYYX Acquisition Sponsor LLC, a Delaware limited liability company (the “ Sponsor ”), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Registration Rights Agreement with certain security holders valued at Registration rights agreement with security holders (effective 2026-02-24).

“A Registration Rights Agreement, dated February 24, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company valued at Trust agreement for IPO proceeds held in trust (effective 2026-02-24).

“An Investment Management Trust Agreement, dated February 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Warrant Agreement with Continental Stock Transfer & Trust Company valued at Warrant Agent agreement for warrants issued in IPO (effective 2026-02-24).

“A Warrant Agreement, dated February 24, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

MOZAYYX Acquisition Corp. entered into Underwriting Agreement with Cantor Fitzgerald & Co. valued at underwriting of 30,000,000 units at $10.00/unit for gross proceeds of $300,000,000 (effective 2026-02-24).

“the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statements: ● An Underwriting Agreement, dated February 24, 2026, by and between the Company and Cantor Fitzgerald & Co., as representative of the underwriters (the “ Representative ”), a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Private Placement Units Purchase Agreement with TRG Latin America Acquisitions LLC (effective 2026-02-25).

“● A Private Placement Units Purchase Agreement, dated February 25, 2026 (the “Private Placement Units Purchase Agreement”), by and between the Company and TRG Latin America Acquisitions LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Registration Rights Agreement with certain security holders (effective 2026-02-25).

“● A Registration Rights Agreement, dated February 25, 2026, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-25).

“● An Investment Management Trust Agreement, dated February 25, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-25).

“● A Rights Agreement, dated February 25, 2026, by and between the Company and Continental Stock Transfer & Trust Company, as Share Rights agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.”

TRG Latin America Acquisitions Corp. entered into Underwriting Agreement with Santander US Capital Markets LLC (effective 2026-02-25).

“● An Underwriting Agreement, dated February 25, 2026, by and between the Company and Santander US Capital Markets LLC, as the sole underwriter, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.”

LISATA THERAPEUTICS, INC. amended Term Sheet Amendment with Kuva Labs Inc. (effective 2026-02-27).

“On February 27, 2026, Lisata and Kuva entered into an amendment to the Term Sheet (the “Term Sheet Amendment”), whereby the parties agreed to extend the expiration date of the Term Sheet to March 7, 2026.”

PRIMEENERGY RESOURCES CORP amended Fifth Amendment with Citibank, N.A., as administrative agent, and the lenders party thereto (effective 2026-02-24).

“On February 24, 2026, PrimeEnergy Resources Corporation (the “Company”), as borrower, entered into a Fifth Amendment (the “Amendment”) to its Fourth Amended and Restated Credit Agreement, dated as of July 5, 2022 (as previously amended, the “Credit Agreement”), with Citibank, N.A., as administrative agent, and the lenders party thereto.”

Viskase Holdings, Inc. amended Eighth Amendment to the Section 382 Rights Agreement with Continental Stock Transfer & Trust Company (effective 2026-02-27).

“On February 27, 2026, Enzon Pharmaceuticals, Inc. (the “ Company ”) entered into the Eighth Amendment to the Section 382 Rights Agreement (the “ Eighth Amendment ”), which amends the Section 382 Rights Agreement, dated as of August 14, 2020 (the “ Rights Agreement ”), by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”

Birchtech Corp. entered into Underwriting Agreement with Lake Street Capital Markets, LLC, as representative of the several underwriters named therein valued at approximately $13.1 million (effective 2026-02-25).

“On February 25, 2026, Birchtech Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets, LLC, as representative of the several underwriters named therein (collectively, the “Underwriters”), relating to the public offering of 6,250,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price per share of $2.40 (the “Offering Price”).”

ODYSSEY MARINE EXPLORATION INC amended Restated JV Agreement with Capital Latinoamericano, S.A. de C.V. and Phosagmex, S.A.P.I. de C.V. (effective 2026-02-27).

“On February 27, 2026, the Company, certain of its affiliates, CapLat, and Phosagmex entered into an amended and restated JV Agreement (the “Restated JV Agreement”).”

ROYAL CARIBBEAN CRUISES LTD entered into Fifth Supplemental Indenture dated February 27, 2026 with The Bank of New York Mellon Trust Company, N.A. valued at Supplement to Base Indenture dated July 31, 2006 governing the 4.750% Senior Notes due 2033 and the (effective 2026-02-27).

“The Notes were issued by the Company pursuant to an indenture, dated as of July 31, 2006 (the “Base Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A. as trustee (the “Trustee”), as supplemented by a Fifth Supplemental Indenture, dated February 27, 2026, between the Company and the Trustee (the “Fifth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”).”

ROYAL CARIBBEAN CRUISES LTD entered into Underwriting Agreement for 4.750% Senior Notes due 2033 and 5.250% Senior Notes due 2038 with J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC valued at Aggregate principal amount of $2,500,000,000 ($1,250,000,000 4.750% Senior Notes due 2033 and $1,250 (effective 2026-02-27).

“On February 27, 2026, Royal Caribbean Cruises Ltd. (the “Company”) completed its previously announced offering of $1,250,000,000 aggregate principal amount of 4.750% Senior Notes due 2033 (the “2033 Notes”) and $1,250,000,000 aggregate principal amount of the Company’s 5.250% Senior Notes due 2038 (the “2038 Notes” and, together with the 2033 Notes, the “Notes”), pursuant to an underwriting agreement, dated as of February 12, 2026 (the “Underwriting Agreement”), among the Company and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and PNC Capital Markets LLC, as representatives of the several underwriters named therein.”

Gentherm Inc amended First Amendment to Second Amended and Restated Credit Agreement with Bank of America, N.A. valued at Amendment permits up to $400 million additional term indebtedness, releases certain borrower/guarant (effective 2026-02-24).

“Item 1.01 Entry into a Material Definitive Agreement. First Amendment to Second Amended and Restated Credit Agreement On February 24, 2026, Gentherm Incorporated (“Gentherm”), together with the other borrowers and guarantors party thereto, entered into that certain First Amendment to Second Amended and Restated Credit Agreement (the “First Amendment”), with the lenders party thereto and Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”), which First Amendment amends that certain Second Amended and Restated Credit Agreement, dated as of June 10, 2022, by and among Gentherm, as a borrower, the other borrowers from time to time party thereto, the lenders from time to time party thereto and the Administrative Agent.”

WESCO INTERNATIONAL INC entered into Indenture, dated as of February 27, 2026, among WESCO Distribution, Inc., the guarantors named therein and U.S. Bank Trust Company, National Association, as trustee with U.S. Bank Trust Company, National Association, as trustee valued at $1.5 billion aggregate principal amount of 5.250% Senior Notes due 2031 and 5.500% Senior Notes due (effective 2026-02-27).

“On February 27, 2026, WESCO Distribution, Inc. (the “Issuer” or “Wesco Distribution”), a wholly owned subsidiary of WESCO International, Inc. (the “Company” or “WESCO”), completed its previously announced offering (the “Offering”) to eligible purchasers of $650 million aggregate principal amount of 5.250% senior notes due 2031 (the “5-Year Notes”) and $850 million aggregate principal amount of 5.500% senior notes due 2034 (the “8-Year Notes” and, together with the 5-Year Notes, the “Notes”).”

STONERIDGE INC entered into Cooperation Agreement with 22NW Fund, LP, 22NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., and Aron R. English (effective 2026-02-26).

“On February 26, 2026, Stoneridge, Inc., an Ohio corporation (the “Company”), entered into a Cooperation Agreement (the “Cooperation Agreement”) with 22NW Fund, LP, a Delaware limited partnership, 22NW, LP, a Delaware limited partnership, 22NW Fund GP, LLC, a Delaware limited liability company, 22NW GP, Inc., a Delaware S corporation, and Aron R. English (collectively, “22NW” or the “Investor Group”).”